Filing Flows › Koru Medical Systems (KRMD) › Q2 2026 › vs Q1 2026
Koru Medical Systems (KRMD) Q2 2026 vs Q1 2026 (quarter over quarter)
Koru Medical Systems's revenue rose $281K (+2%) from $11.8M in Q1 2026 to $12.0M in Q2 2026. Gross margin 65.1% against 61.5% (+3.7 pts).
Koru Medical Systems, Q2 2026: revenue $12.0M (+18% year over year), operating margin 5.2%, net earnings $252K, operating cash flow $216K. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 65.1% | 61.5% | +3.7 pts |
| Operating margin | 5.2% | -7.4% | +12.6 pts |
| Net margin | 2.1% | -6.9% | +9.0 pts |
| Free cash flow margin | 0.9% | -0.3% | +1.2 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $12.0M | $11.8M | $281K | +2% |
| Gross profit | $7.8M | $7.2M | $615K | +9% |
| Cost of revenue | $4.2M | $4.5M | −$334K | -7% |
| Operating profit | $627K | −$865K | $1.5M | — |
| Operating expenses | $7.2M | $8.1M | −$877K | -11% |
| Pre-tax earnings | $258K | −$807K | $1.1M | — |
| Other expense, net | $369K | −$58K | $427K | — |
| Research & development | $1.1M | $1.3M | −$247K | -19% |
| SG&A | $5.9M | $6.6M | −$642K | -10% |
| Other operating costs | $210K | $198K | $12K | +6% |
| Net earnings | $252K | −$807K | $1.1M | — |
| Income tax | $6K | $0 | $6K | — |
| Operating cash sources | $920K | $72K | $848K | 13× |
| Depreciation & amortization | $210K | $198K | $12K | +6% |
| Share-based compensation | $458K | $682K | −$224K | -33% |
| Working capital & other | $704K | $57K | $647K | 12× |
| Operating cash flow | $216K | $15K | $201K | 15× |
| Free cash flow (OCF − capex) | $108K | −$32K | $140K | — |
| Capital expenditures | $108K | $46K | $62K | +134% |
Questions
How much did Koru Medical Systems's revenue grow quarter over quarter in Q2 2026?
Koru Medical Systems's revenue rose $281K (+2%) from $11.8M in Q1 2026 to $12.0M in Q2 2026. Gross margin 65.1% against 61.5% (+3.7 pts).